If you are taking a portfolio company to market in 2026, the "Adjusted EBITDA" game has changed. The days of burying recurring operational costs under the label of "one-time transformation expenses" are finished. Buyers, burned by the valuation inflations of 2021-2022, have weaponized their Quality of Earnings (QofE) processes. They aren't just looking for accuracy; they are looking for reasons to retrade.
The data is stark. Recent 2025 studies indicate that 63% of buyers discovered material financial discrepancies during due diligence that were not disclosed in initial materials. When a buyer finds a discrepancy, they don't just subtract that dollar amount from the purchase price—they apply a multiple to it. A $200k "red flag" add-back at a 12x multiple isn't a $200k problem; it's a $2.4M reduction in enterprise value.
For Operating Partners, the mandate is clear: You cannot rely on a banker's "marketing EBITDA" to hold up under scrutiny. You need a defensible, operator-verified number before you ever sign an LOI. The gap between "Management Adjusted EBITDA" and "Buyer Adjusted EBITDA" is where deals die. This guide categorizes exactly which add-backs are passing due diligence in the current market, and which ones are triggering immediate retrades.

Not all add-backs are created equal. In our work preparing Revenue Quality Audits for exit, we classify adjustments into three tiers: Standard (Green), Aggressive (Yellow), and Toxic (Red). Understanding this distinction is the difference between a smooth close and a 90-day diligence war.
These are universally accepted if documented. Buyers expect these, but they still verify the math.
These trigger scrutiny. Buyers will accept them only with bulletproof data, often requiring a "bridge" analysis.
These are deal-killers. They signal to the buyer that management is dishonest or incompetent.
The most effective defense against price chipping is offense. Data from 2025 shows that sellers who commission a Sell-Side Quality of Earnings report achieve an average valuation multiple of 7.4x, compared to 7.0x for those who don't. That is a 0.4x turn of EBITDA—purely for doing the homework.
Your credibility is an asset class. When a buyer trusts your numbers, they look for reasons to close. When they find phantom add-backs, they look for reasons to walk. Don't give them the ammunition.
